TripleTree Announces Winners of the 2017 TripleTree iAwards

  • Oct 19, 2017
  • Minneapolis, MN

Three transformative healthcare companies are recognized from a group of highly relevant applicants MINNEAPOLIS, MN – TripleTree, a strategic advisor and merchant bank serving innovative and market-leading companies in healthcare, is pleased to announce the winners of the 2017 TripleTree iAwards. The three winners were selected from a group of ten highly relevant companies, each focused on...

Read


XIFIN Launches Next-Generation Sequencing Module; Expands Genomics-based LIS Workflow

  • Oct 5, 2017
  • San Diego, CA

NGS Supports Molecular Business Growth, Laboratory Sequencing Operations and Precision Medicine SAN DIEGO, Calif., -- October 5, 2017 -- XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, today announced that it has expanded its laboratory information system, XIFIN LIS Anywhere, with the launch of a next-generation sequencing module...

Read


XIFIN Highlights Flaws in CMS 2018 Draft PAMA Pricing

  • Sep 25, 2017

Rate Setting Not Market-based and Circumvents Legislative Intent SAN DIEGO, Calif., -- September 25, 2017 -- XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has conducted an initial review of the draft laboratory rates published on Sept. 22 by the Centers for Medicare and Medicaid Services for 2018 clinical laboratory tests under...

Read


XIFIN Named an 11th Time Honoree on Inc. 5000 List of Fastest-Growing Private Companies in America

  • Aug 16, 2017
  • San Diego, CA

XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, and a Frost & Sullivan’s 2017 North American Revenue Cycle Management Company of the Year in the diagnostic laboratory segment, placed on the 2017 Inc. 5000 Fastest-Growing Private U.S. Companies list for the eleventh time — an accomplishment achieved by only a very select group...

Read


Frost & Sullivan Honors XIFIN with Prestigious 2017 North American Revenue Cycle Management for Diagnostic Laboratories Company of the Year Award

  • Jul 31, 2017
  • San Diego, CA

XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has been named Frost & Sullivan’s 2017 North American Revenue Cycle Management Company of the Year in the diagnostic laboratory segment.   Frost & Sullivan analysts followed a proprietary 10-step process to assess XIFIN’s fit against select best practice criteria...

Read


XIFIN Partners with PWNHealth to Offer Lab Services for Direct-to-Consumer Testing, Employer-Based Screening, and Telegenetic Counseling

  • Jun 6, 2017
  • San Diego, CA

Services Provide New Growth Opportunities for XIFIN Customers XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, today announced a partnership agreement with PWNHealth LLC, a virtual care company offering safe and easy access to diagnostic testing services and professional guidance. The agreement allows XIFIN to market PWN’s services...

Read


Attention CFOs of Clinical Lab Companies, Hospitals, and Health Systems: Coming Soon is New FASB Requirement for Recognizing Revenue from Contracts

  • May 23, 2017
  • AUSTIN, Texas

Big changes are coming for chief financial officers at laboratory companies, hospitals, and health systems that report financial performance using GAAP. CFOs at these organizations will soon be required to comply with the new FASB Rule 606–Revenue Recognition Standard. That means all contracts, including managed care contracts and patient self-pay arrangements, must be reported in a different...

Read


Former Pathology, Inc. CEO Vicki DiFrancesco Joins XIFIN as Chief Strategy Officer

  • Apr 25, 2017
  • San Diego, CA

XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has appointed Vicki DiFrancesco as its Chief Strategy Officer. DiFrancesco, one of the most influential leaders in the laboratory industry, will be responsible for building and executing XIFIN’s corporate business development strategies including acquisitions, joint ventures and...

Read